Band 6+: The chart below shows how much money five big pharmaceutical companies spent on research in 2012 and 2018 and gives an estimate of the amounts spent in 2022. Describe the data providing an overview of the general trends, reporting the main features, and making comparisons.

the bar chart shows the amoun of money spent on survey by five big companies in the pharmaceutic field.

Every company has increased their spents, Novas are became the biggest research spender along with Fleming, and Pharm, despite being the biggest one in the first peiod, is predicted to become the least spending on research company.

Novas and Fleming are both predicted to spend the most money in 2022 with about 58 and 31 billion dollars respectively. They both also spent the highest amoun on money on research in 2018, but Fleming spent less than Novas by around 2 billion dollars. However, Novas was not a top spending company in 2012, while Fleming was the second most spending company with 5 billion dollars investment in research, which is two times more than Novas spent in the same year.

Speaking about 3 companies that estimated to spent the least amount of money on research in 2022, we can say that their investitions in 2012 was quite different: Pharm has spent about ten times more money than Biopharm and three times more than Avicenna, and its spending was 10 billion dollars. However, in 2022 all three companies are predicted to spend approximately same amount of money, which is around 22-25 billion dollars.